Deutsche Bank’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Deutsche Bank’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,207	Closed	-$44.6K	–	3726
2024 Q1	$44.6K	Buy	12,207 +10,669	+694%	+$40.9K	﹤0.01%	3419
2023 Q4	$4.63K	Hold	1,538	–	–	﹤0.01%	3571
2023 Q3	$3.31K	Hold	1,538	–	–	﹤0.01%	3623
2023 Q2	$8.61K	Buy	+1,538	New	+$12K	﹤0.01%	3659
2022 Q2	–	Sell	-12,337	Closed	-$77K	–	4364
2022 Q1	$77K	Buy	12,337 +7,841	+174%	+$80K	﹤0.01%	3680
2021 Q4	$51K	Buy	4,496 +240	+6%	+$4.56K	﹤0.01%	3952
2021 Q3	$80K	Buy	+4,256	New	+$81.6K	﹤0.01%	3980

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Deutsche Bank's OMGA Position: Q2 2024 in Review

Deutsche Bank sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 12,207 shares — an estimated $44.6K sold.

Deutsche Bank first reported a position in OMGA in Q3 2021 and held it in 7 quarters. The position peaked at $80K in Q3 2021. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

Deutsche Bank reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Deutsche Bank sold 12,207 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $44.6K.
Deutsche Bank first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Deutsche Bank's Omega Therapeutics, Inc. Common Stock position peaked at $80K in Q3 2021.
68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.